DE69302977T2 - Verfahren zur Anomizierung von Nukleosiden - Google Patents

Verfahren zur Anomizierung von Nukleosiden

Info

Publication number
DE69302977T2
DE69302977T2 DE69302977T DE69302977T DE69302977T2 DE 69302977 T2 DE69302977 T2 DE 69302977T2 DE 69302977 T DE69302977 T DE 69302977T DE 69302977 T DE69302977 T DE 69302977T DE 69302977 T2 DE69302977 T2 DE 69302977T2
Authority
DE
Germany
Prior art keywords
nucleosides
anomicating
anomer
anomeric mixture
nucleoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69302977T
Other languages
English (en)
Other versions
DE69302977D1 (de
Inventor
Thomas Charles Britton
Tourneau Michael Edward Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69302977D1 publication Critical patent/DE69302977D1/de
Publication of DE69302977T2 publication Critical patent/DE69302977T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69302977T 1992-09-01 1993-08-31 Verfahren zur Anomizierung von Nukleosiden Expired - Lifetime DE69302977T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93879192A 1992-09-01 1992-09-01

Publications (2)

Publication Number Publication Date
DE69302977D1 DE69302977D1 (de) 1996-07-11
DE69302977T2 true DE69302977T2 (de) 1996-10-31

Family

ID=25471966

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69302977T Expired - Lifetime DE69302977T2 (de) 1992-09-01 1993-08-31 Verfahren zur Anomizierung von Nukleosiden

Country Status (15)

Country Link
US (1) US5420266A (de)
EP (1) EP0587364B1 (de)
JP (1) JP3462893B2 (de)
KR (1) KR100252451B1 (de)
AT (1) ATE138929T1 (de)
BR (1) BR9303658A (de)
CA (1) CA2105112C (de)
DE (1) DE69302977T2 (de)
DK (1) DK0587364T3 (de)
ES (1) ES2090880T3 (de)
GR (1) GR3020426T3 (de)
HU (1) HU214980B (de)
IL (1) IL106840A (de)
MX (1) MX9305301A (de)
TW (1) TW356472B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
US5869461A (en) * 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
CA2171518A1 (en) * 1995-03-24 1996-09-25 Douglas Patton Kjell Process for the preparation of 2,2'-anhydro- and 2' -keto-1-(3', 5'-di-o-protected-.beta.-d-arabinofuranosyl) nucleosides
US5633367A (en) * 1995-03-24 1997-05-27 Eli Lilly And Company Process for the preparation of a 2-substituted 3,3-difluorofuran
US6013790A (en) * 1996-09-25 2000-01-11 Board Of Regents University Of Nebraska-Lincoln Heavily fluorinated sugar analogs
US6248878B1 (en) * 1996-12-24 2001-06-19 Ribozyme Pharmaceuticals, Inc. Nucleoside analogs
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
EA200601591A1 (ru) 2000-05-26 2007-02-27 Айденикс (Кайман) Лимитед Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
KR100467016B1 (ko) * 2002-05-30 2005-01-24 삼성전자주식회사 반도체기판의 세정방법
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
BR0312278A (pt) 2002-06-28 2007-06-19 Idenix Cayman Ltd éster 2'-c-metil-3'-o-l-valina de ribofuranosil citidina para tratamento de infecções por flaviviridae
DK1576138T3 (en) 2002-11-15 2017-05-01 Idenix Pharmaceuticals Llc 2'-METHYL NUCLEOSIDES IN COMBINATION WITH INTERFERON AND FLAVIVIRIDAE MUTATION
EP2345658A1 (de) * 2003-05-30 2011-07-20 Pharmasset, Inc. Modifizierte fluorinierte Nukleosidanaloga
CN101023094B (zh) * 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
RU2433124C2 (ru) * 2004-09-14 2011-11-10 Фармассет, Инк. Способ получения 2'-фтор-2'-алкилзамещенных или других замещенных рибофуранозилпиримидинов и пуринов и их производных
WO2006092808A1 (en) * 2005-03-04 2006-09-08 Dabur Pharma Limited Intermediate and process for preparing of beta- anomer enriched 21deoxy, 21 ,21-difluoro-d-ribofuranosyl nucleosides
ES2422290T3 (es) 2005-12-23 2013-09-10 Idenix Pharmaceuticals Inc Procedimiento para preparar un producto intermedio sintético para la preparación de nucleósidos ramificados
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
PA8855801A1 (es) 2008-12-23 2010-07-27 Sintesis de nucleosidos de purina
AR074897A1 (es) 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
EP2376514A2 (de) * 2008-12-23 2011-10-19 Pharmasset, Inc. Nukleosidanaloga
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
US8859756B2 (en) 2010-03-31 2014-10-14 Gilead Pharmasset Llc Stereoselective synthesis of phosphorus containing actives
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
ES2716158T3 (es) 2010-11-30 2019-06-10 Gilead Pharmasset Llc 2'-spiro-nucleótidos para el tratamiento de hepatitis C
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
CN102603838B (zh) * 2012-02-14 2015-02-18 江苏八巨药业有限公司 一种制备吉西他滨盐酸盐的方法
PL3038601T3 (pl) 2013-08-27 2020-08-24 Gilead Pharmasset Llc Formulacja złożona dwóch związków przeciwwirusowych
AU2019296174B2 (en) 2018-06-29 2021-10-07 Changchun Changcheng Pharmaceutical Technology Co., LTD Phosphorus-containing prodrugs of gemcitabine

Also Published As

Publication number Publication date
DK0587364T3 (da) 1996-07-01
CA2105112A1 (en) 1994-03-02
HU214980B (hu) 1998-08-28
US5420266A (en) 1995-05-30
JP3462893B2 (ja) 2003-11-05
KR100252451B1 (ko) 2000-04-15
GR3020426T3 (en) 1996-10-31
ES2090880T3 (es) 1996-10-16
EP0587364B1 (de) 1996-06-05
JPH06157571A (ja) 1994-06-03
ATE138929T1 (de) 1996-06-15
IL106840A0 (en) 1993-12-08
KR940007053A (ko) 1994-04-26
HU9302452D0 (en) 1993-11-29
TW356472B (en) 1999-04-21
BR9303658A (pt) 1994-03-22
CA2105112C (en) 2005-08-02
HUT65137A (en) 1994-04-28
DE69302977D1 (de) 1996-07-11
MX9305301A (es) 1994-06-30
EP0587364A1 (de) 1994-03-16
IL106840A (en) 1998-09-24

Similar Documents

Publication Publication Date Title
ATE138929T1 (de) Verfahren zur anomizierung von nukleosiden
ATE155476T1 (de) Verfahren zur herstellung von mit alpha-anomeren angereichterten 2-deoxy-2,2-difluor-d- ribofuranosyl sulfonaten
UA41261C2 (uk) Спосіб одержання збагачених бета-аномером нуклеозидів
ATE140923T1 (de) Verfahren zur herstellung von n4-acyl-5'-desoxy-5-fluorocytidinderivate
DK572788D0 (da) Polysvovlsyreestere af bis-aldonamider og derivater deraf samt fremgangsmaade til fremstilling af samme
DE69020481T2 (de) Verfahren und Vorrichtung zum Biegen von Glas.
DE69308391D1 (de) Verfahren zur Trennung von 2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Alkyl-Sulfonat-Anomeren
ATE189195T1 (de) Verfahren und vorrichtung zum biegen von glasscheiben
DE69010030T2 (de) Verfahren zur Produktion von Fruktose-1,6-diphosphat.
EP0328959A3 (de) Verfahren zur Reinigung von langkettigen Alkylglucosiden
EP0640614A3 (de) Stereoselektives Verfahren zur Herstellung von Beta-Anomer angereicherten 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy-geschützten 1-alkyl und aryl-sulfonat-Zwischenprodukten.
DE3581984D1 (de) Vorrichtung zum reinigen von glastafeln.
DE3885135D1 (de) Verfahren zum Entfernen von Sägehilfsmittelresten von Scheiben.
DE3765584D1 (de) Verfahren und vorrichtung zum biegen von glasplatten.
DE3781913D1 (de) Verfahren zur herstellung von makrolid-verbindungen.
AU7060191A (en) Process for removing organic trace substances from flue gases
ATE312116T1 (de) Verfahren zur herstellung von nukleosid-derivaten
ATE103232T1 (de) Verfahren zum drehrichten von brettern u.dgl.
IL102143A0 (en) Process for selectively isolating 2-deoxy-2,2-difluoro-d-erythro-pentofuranos-1-ulose-3,5-dibenzoate
ATE100428T1 (de) Vorrichtung und verfahren zum abschrecken von glasblaettern.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN